HealthFlex
×
  • Home
  • About Us
  • Our Team
  • Products
  • Latest News
  • Careers
  • Contact

Jan 2, 2019

Slayback Pharma announces FDA approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 mL in a multi-dose vial, the first generic equivalent of Makena® Injection 1,250 mg/ 5 mL multi-dose vial

Add Comment Cancel


Recent Posts

  • Apr 15, 2021
  • Feb 4, 2021
  • Dec 18, 2020
  • Dec 7, 2020
  • Sep 2, 2020

Slayback Pharma LLC

(+1) 609 945 3443

contact@slayback-pharma.com

301 Carnegie Center, Suite 303, Princeton, NJ 08540

Copyright ©2021 all rights reserved